Xarelto is a blood thinner, otherwise known as an anticoagulant. In short, Xarleto was designed stop blood clots that can travel to your heart or brain and severely injure or kill you. Xarelto was created and marketed by Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals. It’s purportedly safer and easier to use than alternative blood thinners, and it’s taken orally. Approved by the Food and Drug Administration in 2011, it’s primarily used to prevent pulmonary embolism for those who have had kip or knee replacements. It’s also used to reduce the risk of stroke with patients who experience an irregular heartbeat. It is alleged that Xarelto comes with the chance of bleeding to death internally.
Are there are serious risks with Xarelto? The Lawsuit Claimants Say Yes!
Because of the risk of hemorrhage, blood thinners often require periodic medical monitoring through doctor visits along with the patient’s self-intervention with dietary and lifestyle changes. While previous blood thinner medications required regular doctor visits and alterations to a person’s lifestyle and dietary habits, it is claimed that Xarelto is sold and marketed as an alternative which does not require the constant check-ups and the drastic lifestyle changes. These intended benefits do not come without certain risks though. Suspected of causing serious internal bleeding, and unlike other blood thinners, Xarelto does not have an FDA approved antidote for emergency situations. The lack of an antidote can cause the bleeding to become uncontrolled, and the manufacturers of Xarelto have yet to provide doctors with sufficient information on how to combat such a situation.
Individuals allegedly injured by Xarelto and others who believe that family members have died from the drug have filed lawsuits against Johnson & Johnson and Jannssen in Federal courts across the United States. By the middle of 2015, more than 2000 Xarelto lawsuits were filed, and the number continues to grow. Because of the burden of these lawsuits coupled with the commonality of issues, the U.S. Judicial Panel on Multidistrict Litigation transferred all lawsuits involving injuries or deaths alleged to be connected to Xarelto to the U.S. District Court for the Eastern District of Louisiana. Those cases are pending in an MDL vs Class Action Status.
The anti-coagulant market is estimated to bring in $10 billion a year. Thousands of lawsuits with the same allegations were brought in state and federal courts against German drug manufacturer Boehringer Ingelheim, who also didn’t have a solution to bleeding when its blood thinner, Pradaxa was used. Pradaxa was only approved by the U.S. Food and Drug Administration in 2010, and by 2011, it was alleged that more than 540 patients had lost their lives while using the blood thinner. Others had testified of their experiences with very serious side effects. Boehringer Ingelheim has agreed to pay $650 million to settle those state and federal lawsuits.
The Ledger Law Firm is assisting claimants with information related to the viability of a lawsuit against the manufactures of Xarelto. Our attorneys possess the knowledge, experience, compassion and dedication necessary in successfully resolving the claims of injury victims against pharmaceutical manufacturers and marketers. If you or somebody in your family experienced a significant bleeding event while using Xarelto, contact us right away. There are limitations on claim periods.